These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9791158)

  • 21. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.
    Figueras J; Ibañez L; Ramos E; Jaurrieta E; Ortiz-de-Urbina J; Pardo F; Mir J; Loinaz C; Herrera L; López-Cillero P; Santoyo J
    Liver Transpl; 2001 Oct; 7(10):877-83. PubMed ID: 11679986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
    Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
    Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
    Tamura S; Kato T; Berho M; Misiakos EP; O'Brien C; Reddy KR; Nery JR; Burke GW; Schiff ER; Miller J; Tzakis AG
    Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation.
    Peterson MS; Baron RL; Marsh JW; Oliver JH; Confer SR; Hunt LE
    Radiology; 2000 Dec; 217(3):743-9. PubMed ID: 11110938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of hepatocellular carcinoma after liver transplantation.
    Escartin A; Sapisochin G; Bilbao I; Vilallonga R; Bueno J; Castells L; Dopazo C; Castro E; Caralt M; Balsells J
    Transplant Proc; 2007 Sep; 39(7):2308-10. PubMed ID: 17889173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma and liver transplantation: a 12-year experience.
    Varona MA; Del Pino JM; Barrera M; Arranz J; Hernández BM; Perez HF; Padilla J; Fuentes JS; Aguirre A; Mendez S; Sanz P; Gianchandani R; Perera A; Soriano A
    Transplant Proc; 2009 Apr; 41(3):1005-8. PubMed ID: 19376411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation for malignant diseases: selection and pattern of recurrence.
    Margarit C; Charco R; Hidalgo E; Allende H; Castells L; Bilbao I
    World J Surg; 2002 Feb; 26(2):257-63. PubMed ID: 11865357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
    Mazzaferro V; Sposito C; Zhou J; Pinna AD; De Carlis L; Fan J; Cescon M; Di Sandro S; Yi-Feng H; Lauterio A; Bongini M; Cucchetti A
    Gastroenterology; 2018 Jan; 154(1):128-139. PubMed ID: 28989060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation.
    Rosenkrantz AB; Campbell N; Wehrli N; Triolo MJ; Kim S
    Radiology; 2015 Feb; 274(2):426-33. PubMed ID: 25299785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
    Duffy JP; Vardanian A; Benjamin E; Watson M; Farmer DG; Ghobrial RM; Lipshutz G; Yersiz H; Lu DS; Lassman C; Tong MJ; Hiatt JR; Busuttil RW
    Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological features of incidental hepatocellular carcinoma in liver transplantation.
    Choi SH; Lee HH; Lee DS; Choi JH; Heo JS; Lee KW; Joh JW; Kim SJ; Yoo BC; Lee JH; Choi MS; Choe YH; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2293-4. PubMed ID: 15561224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Yi NJ; Lee KU
    Liver Transpl; 2006 Nov; 12(11):1655-60. PubMed ID: 16964589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
    Cheung TT; Chan SC; Ho CL; Chok KS; Chan AC; Sharr WW; Ng KK; Poon RT; Lo CM; Fan ST
    Liver Transpl; 2011 Oct; 17(10):1218-25. PubMed ID: 21688383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
    Sakai K; Okajima H; Koshino K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Ochiai T; Yoshimura N
    Transplant Proc; 2012 Mar; 44(2):409-11. PubMed ID: 22410029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting survival and tumor recurrence in patients transplanted for hepatocellular carcinoma and coexistent hepatitis C virus.
    Briceño J; Ruiz J; Ciria R; Naranjo A; Sánchez-Hidalgo J; Luque A; Rufián S; de la Mata M; López-Cillero P
    Transplant Proc; 2008 Nov; 40(9):2990-3. PubMed ID: 19010170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of liver transplantation in malignant liver tumors associated with tyrosinemia: clinical and laboratory findings of five cases.
    Büyükpamukçu M; Varan A; Haberal M; Büyükpamukçu N; Köksal Y; Coşkun T; Yüce A; Kale G; Akyüz C; Kutluk T
    Pediatr Transplant; 2006 Jun; 10(4):517-20. PubMed ID: 16712614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.